trans-Aconitic acid

Details

Top
Internal ID 53ad46d0-e025-4403-b9c2-7ae1a22caca3
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Tricarboxylic acids and derivatives
IUPAC Name (E)-prop-1-ene-1,2,3-tricarboxylic acid
SMILES (Canonical) C(C(=CC(=O)O)C(=O)O)C(=O)O
SMILES (Isomeric) C(/C(=C\C(=O)O)/C(=O)O)C(=O)O
InChI InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1+
InChI Key GTZCVFVGUGFEME-HNQUOIGGSA-N
Popularity 1,170 references in papers

Physical and Chemical Properties

Top
Molecular Formula C6H6O6
Molecular Weight 174.11 g/mol
Exact Mass 174.01643791 g/mol
Topological Polar Surface Area (TPSA) 112.00 Ų
XlogP -1.00
Atomic LogP (AlogP) -0.44
H-Bond Acceptor 3
H-Bond Donor 3
Rotatable Bonds 4

Synonyms

Top
4023-65-8
(E)-prop-1-ene-1,2,3-tricarboxylic acid
trans-Aconitate
(E)-1-Propene-1,2,3-tricarboxylic acid
ACONITIC ACID
(E)-Aconitic acid
Aconitic acid, (E)-
ACONITIC ACID, TRANS
(1E)-prop-1-ene-1,2,3-tricarboxylic acid
trans Aconitic acid
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of trans-Aconitic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8319 83.19%
Caco-2 - 0.7270 72.70%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.7588 75.88%
OATP2B1 inhibitior - 0.8597 85.97%
OATP1B1 inhibitior + 0.9482 94.82%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9888 98.88%
P-glycoprotein inhibitior - 0.9837 98.37%
P-glycoprotein substrate - 0.9811 98.11%
CYP3A4 substrate - 0.7582 75.82%
CYP2C9 substrate - 0.7552 75.52%
CYP2D6 substrate - 0.8984 89.84%
CYP3A4 inhibition - 0.9523 95.23%
CYP2C9 inhibition - 0.9433 94.33%
CYP2C19 inhibition - 0.9662 96.62%
CYP2D6 inhibition - 0.9407 94.07%
CYP1A2 inhibition - 0.9507 95.07%
CYP2C8 inhibition - 0.9858 98.58%
CYP inhibitory promiscuity - 0.9733 97.33%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6135 61.35%
Carcinogenicity (trinary) Non-required 0.6807 68.07%
Eye corrosion + 0.7749 77.49%
Eye irritation + 0.9908 99.08%
Skin irritation + 0.5000 50.00%
Skin corrosion + 0.7960 79.60%
Ames mutagenesis - 0.9800 98.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8675 86.75%
Micronuclear - 0.7200 72.00%
Hepatotoxicity + 0.6053 60.53%
skin sensitisation + 0.4769 47.69%
Respiratory toxicity - 0.7111 71.11%
Reproductive toxicity - 0.8556 85.56%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity - 0.6277 62.77%
Acute Oral Toxicity (c) III 0.7914 79.14%
Estrogen receptor binding - 0.9348 93.48%
Androgen receptor binding - 0.7204 72.04%
Thyroid receptor binding - 0.9198 91.98%
Glucocorticoid receptor binding - 0.6765 67.65%
Aromatase binding - 0.9008 90.08%
PPAR gamma - 0.7758 77.58%
Honey bee toxicity - 0.9459 94.59%
Biodegradation + 0.7000 70.00%
Crustacea aquatic toxicity - 0.8900 89.00%
Fish aquatic toxicity + 0.7773 77.73%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293226 B2RXH2 Lysine-specific demethylase 4D-like 39810.7 nM
Potency
via CMAUP
CHEMBL1963 P16473 Thyroid stimulating hormone receptor 5011.9 nM
5011.9 nM
Potency
Potency
via CMAUP
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3060 Q9Y345 Glycine transporter 2 85.12% 99.17%
CHEMBL221 P23219 Cyclooxygenase-1 83.21% 90.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 81.96% 91.11%
CHEMBL1255126 O15151 Protein Mdm4 80.39% 90.20%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 80.02% 100.00%

Cross-Links

Top
PubChem 444212
NPASS NPC137419
ChEMBL CHEMBL153658
LOTUS LTS0049047
wikiData Q27104227